Cantor Maria E
SVP, Investor Relations & Comm at QURE; SVP, Corporate Affairs at ARIAD PHARMACEUTICALS INC
- Sold, on record
- $2.1M
- Dollars the filings state
- Form 4 sales
- 26
- Latest Jan 3, 2018
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- QUREuniQure N.V.SVP, Investor Relations & Comm
- ARIAD PHARMACEUTICALS INCSVP, Corporate Affairs
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- ARIAD PHARMACEUTICALS INC173,000 shares
- QURE5,864 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale ARIAD PHARMACEUTICALS INCPlan not statedJul 16, 2015 2015
Sold 4,000 shares at $8.54 ($34k)
Cantor Maria E, SVP, Corporate Affairs
Sold 3.5% of holdings ($964k position)108,881 shares left0.9x usual sizeFiling
- 2 Form 4 sale ARIAD PHARMACEUTICALS INCPlan not statedAug 28, 2015 +43 days
Sold 1,268 shares at $10.00 ($13k)
Cantor Maria E, SVP, Corporate Affairs
Sold 1.2% of holdings ($1.1M position)107,613 shares left0.3x usual sizeFiling
- 3 Form 4 sale ARIAD PHARMACEUTICALS INCPlan not statedSep 1, 2015 +4 days
Sold 2,696 shares at $9.11 ($25k)
Cantor Maria E, SVP, Corporate Affairs
Sold 2.5% of holdings ($980k position)104,917 shares left0.7x usual sizeFiling
- 4 Form 4 sale ARIAD PHARMACEUTICALS INCPlan not statedSep 28, 2015 +27 days
Sold 5,000 shares at $6.47 ($32k)
Cantor Maria E, SVP, Corporate Affairs
Sold 4.4% of holdings ($744k position)109,917 shares left1.3x usual sizeFiling
- 5 Form 4 sale ARIAD PHARMACEUTICALS INCUnusualFeb 1, 2016 +126 days
Sold 16,133 shares at $4.82 ($78k)
Cantor Maria E, SVP, Corporate Affairs
Sold 11.6% of holdings ($671k position)123,117 shares left4.3x usual sizeFiling
- 6 Form 4 sale ARIAD PHARMACEUTICALS INCPlan not statedMar 3, 2016 +31 days
Sold 9,625 shares at $6.12 ($59k)
Cantor Maria E, SVP, Corporate Affairs
Sold 6.8% of holdings ($871k position)132,742 shares left2.5x usual sizeFiling
- 7 Form 4 sale ARIAD PHARMACEUTICALS INCPlan not statedMar 19, 2016 +16 days
Sold 3,575 shares at $6.46 ($23k)
Cantor Maria E, SVP, Corporate Affairs
Sold 2.6% of holdings ($900k position)135,667 shares left0.9x usual sizeFiling
- 8 Form 4 sale QUREPlan not statedJan 3, 2018 +655 days
Sold 5,864 shares at $20.13 ($118k)
Cantor Maria E, SVP, Investor Relations & Comm
Sold 6.4% of holdings ($1.8M position)85,251 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (26)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2018 | Jan 3, 2018 | QURE | SVP, Investor Relations & Comm | Form 4 sale | 5,864 | $118k | 6.4% | Plan not stated | SEC |
| Mar 19, 2016 | Mar 22, 2016 | ARIAD PHARMACEUTICALS INC | SVP, Corporate Affairs | Form 4 sale | 3,575 | $23k | 2.6% | Plan not stated | SEC |
| Mar 3, 2016 | Mar 3, 2016 | ARIAD PHARMACEUTICALS INC | SVP, Corporate Affairs | Form 4 sale | 9,625 | $59k | 6.8% | Plan not stated | SEC |
| Feb 1, 2016 | Feb 3, 2016 | ARIAD PHARMACEUTICALS INC | SVP, Corporate Affairs | Form 4 sale | 16,133 | $78k | 11.6% | Unusual | SEC |
| Sep 28, 2015 | Sep 28, 2015 | ARIAD PHARMACEUTICALS INC | SVP, Corporate Affairs | Form 4 sale | 5,000 | $32k | 4.4% | Plan not stated | SEC |
| Sep 1, 2015 | Sep 3, 2015 | ARIAD PHARMACEUTICALS INC | SVP, Corporate Affairs | Form 4 sale | 2,696 | $25k | 2.5% | Plan not stated | SEC |
| Aug 28, 2015 | Sep 1, 2015 | ARIAD PHARMACEUTICALS INC | SVP, Corporate Affairs | Form 4 sale | 1,268 | $13k | 1.2% | Plan not stated | SEC |
| Jul 16, 2015 | Jul 16, 2015 | ARIAD PHARMACEUTICALS INC | SVP, Corporate Affairs | Form 4 sale | 4,000 | $34k | 3.5% | Plan not stated | SEC |
| Mar 23, 2015 | Mar 23, 2015 | ARIAD PHARMACEUTICALS INC | SVP, Corporate Affairs and HR | Form 4 sale | 16,954 | $150k | 13.9% | Unusual | SEC |
| Feb 2, 2015 | Feb 4, 2015 | ARIAD PHARMACEUTICALS INC | SVP, Corporate Affairs and HR | Form 4 sale | 16,134 | $102k | 13.9% | Unusual | SEC |
| Nov 24, 2014 | Nov 25, 2014 | ARIAD PHARMACEUTICALS INC | SVP, Corporate Affairs and HR | Form 4 sale | 1,749 | $12k | 2.0% | Plan not stated | SEC |
| Sep 2, 2014 | Sep 4, 2014 | ARIAD PHARMACEUTICALS INC | SVP, Corporate Affairs and HR | Form 4 sale | 2,696 | $17k | 3.0% | Plan not stated | SEC |
| Jun 2, 2014 | Jun 4, 2014 | ARIAD PHARMACEUTICALS INC | SVP, Corporate Affairs and HR | Form 4 sale | 3,713 | $26k | 4.2% | Plan not stated | SEC |
| Apr 2, 2014 | Apr 3, 2014 | ARIAD PHARMACEUTICALS INC | SVP, Corporate Affairs and HR | Form 4 sale | 4,250 | $35k | 4.6% | Plan not stated | SEC |
| Mar 21, 2014 | Mar 21, 2014 | ARIAD PHARMACEUTICALS INC | SVP, Corporate Affairs and HR | Form 4 sale | 3,667 | $29k | 4.3% | Plan not stated | SEC |
| Dec 19, 2013 | Dec 20, 2013 | ARIAD PHARMACEUTICALS INC | SVP, Corporate Affairs | Form 4 sale | 6,375 | $33k | 7.9% | Plan not stated | SEC |
| Jul 18, 2013 | Jul 18, 2013 | ARIAD PHARMACEUTICALS INC | SVP, Corporate Affairs | Form 4 sale | 8,000 | $158k | 10.6% | Plan not stated | SEC |
| Apr 2, 2013 | Apr 3, 2013 | ARIAD PHARMACEUTICALS INC | SVP, Corporate Affairs | Form 4 sale | 4,250 | $77k | 6.4% | Plan not stated | SEC |
| Mar 22, 2013 | Mar 22, 2013 | ARIAD PHARMACEUTICALS INC | SVP, Corporate Affairs | Form 4 sale | 3,667 | $71k | 8.0% | Plan not stated | SEC |
| Mar 12, 2013 | Mar 13, 2013 | ARIAD PHARMACEUTICALS INC | SVP, Corporate Affairs | Form 4 sale | 2,105 | $46k | 5.2% | Plan not stated | SEC |
| Jul 30, 2012 | Aug 1, 2012 | ARIAD PHARMACEUTICALS INC | SVP, Corporate Affairs | Form 4 sale | 6,478 | $123k | 16.5% | Plan not stated | SEC |
| Jun 25, 2012 | Jun 26, 2012 | ARIAD PHARMACEUTICALS INC | SVP, Corporate Affairs | Form 4 sale | 1,765 | $30k | 5.2% | Plan not stated | SEC |
| Jun 19, 2012 | Jun 21, 2012 | ARIAD PHARMACEUTICALS INC | SVP, Corporate Affairs | Form 4 sale | 7,500 | $135k | 18.0% | Plan not stated | SEC |
| Apr 3, 2012 | Apr 3, 2012 | ARIAD PHARMACEUTICALS INC | SVP, Corporate Affairs | Form 4 sale | 3,400 | $55k | 9.3% | Plan not stated | SEC |
| Mar 27, 2012 | Mar 28, 2012 | ARIAD PHARMACEUTICALS INC | SVP, Corporate Affairs | Form 4 sale | 24,000 | $388k | 46.0% | Unusual | SEC |
| Mar 20, 2012 | Mar 21, 2012 | ARIAD PHARMACEUTICALS INC | SVP, Corporate Affairs | Form 4 sale | 14,000 | $210k | 33.1% | Unusual | SEC |